Sodium Channel Blocker Tolerance as a Metric for Disease Modification in Dravet Syndrome.

zorevunersen (STK-001) - Stoke Therap

Sodium Channel Blocker Tolerance as a Metric for Disease Modification in Dravet Syndrome. (PubMed, Ann Child Neurol Soc) - Sep 18, 2026 - No abstract available
Journal • CNS Disorders • Epilepsy

http://www.ncbi.nlm.nih.gov/pubmed/42751588

Koichiro Yuji; Wakako Yuji

Sep 18, 2026